tizanidine

Generic: tizanidine

Labeler: redpharm drug
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tizanidine
Generic Name tizanidine
Labeler redpharm drug
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tizanidine hydrochloride 2 mg/1

Manufacturer
Redpharm Drug

Identifiers & Regulatory

Product NDC 67296-2209
Product ID 67296-2209_49add032-3efc-19f3-e063-6394a90a0d21
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091283
Listing Expiration 2027-12-31
Marketing Start 2013-04-01

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 672962209
Hyphenated Format 67296-2209

Supplemental Identifiers

RxCUI
313412
UPC
0329300168150 0329300169157
UNII
B53E3NMY5C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tizanidine (source: ndc)
Generic Name tizanidine (source: ndc)
Application Number ANDA091283 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 21 TABLET in 1 BOTTLE, PLASTIC (67296-2209-1)
source: ndc

Packages (1)

Ingredients (1)

tizanidine hydrochloride (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "49add032-3efc-19f3-e063-6394a90a0d21", "openfda": {"upc": ["0329300168150", "0329300169157"], "unii": ["B53E3NMY5C"], "rxcui": ["313412"], "spl_set_id": ["49adcfc8-3b1d-7f7e-e063-6294a90a361e"], "manufacturer_name": ["Redpharm Drug"]}, "finished": true, "packaging": [{"sample": false, "description": "21 TABLET in 1 BOTTLE, PLASTIC (67296-2209-1)", "package_ndc": "67296-2209-1", "marketing_start_date": "20130401"}], "brand_name": "Tizanidine", "product_id": "67296-2209_49add032-3efc-19f3-e063-6394a90a0d21", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "67296-2209", "generic_name": "Tizanidine", "labeler_name": "Redpharm Drug", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA091283", "marketing_category": "ANDA", "marketing_start_date": "20130401", "listing_expiration_date": "20271231"}